Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06805201 · ClinicalTrials.gov registry record · NA
The Effects of Gyngerlean Supplementation on Energy Expenditure
A NA study of Metabolism and No Disease or Condition is Being Studied, sponsored by Nova Southeastern University.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT06805201 is a NA study of Metabolism and No Disease or Condition is Being Studied that has completed, run by Nova Southeastern University. The registered enrollment target is 10 participants, below the 13,265-participant average among 19 other Metabolism trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06805201, a NA study of Metabolism and No Disease or Condition is Being Studied, has completed, sponsored by Nova Southeastern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this randomized controlled study is to asses the effects of a ginger containing supplement on energy expenditure and substrate utilization in healthy men. The main questions it aims to answer are" * The effects of Kaempferia parviflora extract on energy expenditure * The effects of Kaempferia parviflora extract on substrate utilization
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Gyngerlean
Study Locations (1)
Florida
- Nova Southeastern University - Davie
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2024-07-23 |
| Est. Completion | 2024-08-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06805201
The ClinicalTrials.gov registry entry for NCT06805201 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 13,265-participant average among 19 other Metabolism trials with a reported enrollment target (100% lower). The listed sponsor is Nova Southeastern University, which has 71 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Metabolism appearing as the primary indexed condition, and to 1 intervention - of which Gyngerlean is the first listed.
NCT06805201 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT06805201 about?
NCT06805201 is a clinical study titled "The Effects of Gyngerlean Supplementation on Energy Expenditure". The goal of this randomized controlled study is to asses the effects of a ginger containing supplement on energy expenditure and substrate utilization in healthy men. The main questions it aims to answer are" * The effects of Kaempferia parviflora extract on energy expenditure * The effects of Kaem...
What is the current status of trial NCT06805201?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2024-07-23. Estimated completion is 2024-08-08.
What conditions does trial NCT06805201 study?
This clinical trial studies the following conditions: Metabolism, No Disease or Condition is Being Studied.
What interventions are being tested in trial NCT06805201?
The interventions under investigation include: Gyngerlean (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06805201?
This trial is sponsored by Nova Southeastern University, which has 71 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06805201 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Metabolism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
GLYLO Supplement Pilot Trial on Glycation and Aging in Postmenopausal Women
RECRUITING · NA
-
Tracing Of Real-time glu13Cose Metabolism in Human Immune Cells
RECRUITING · NA
-
Personalized Responses to Dietary Composition Trial 3
RECRUITING · NA
-
Study of Clinical Response to Acute Metformin By Leveraging Evaluations During a Mixed Meal Tolerance Test for Exploring Glycemia and GeneticS
ACTIVE NOT RECRUITING · NA
-
Duration of Physical Inactivity and Postprandial Lipid Metabolism
COMPLETED · NA
-
Effects of a Caffeine- and Protein-Containing Coffee Beverage on Metabolism and Muscular Performance
COMPLETED · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.